Penelope A. Fenner-Crisp

IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical Carcinogenesis

C. Sonich-Mullin, R.J. Fielder, Jeanette Wiltse et al. · Regulatory Toxicology and Pharmacology · 2001 · 348 citations

Pharmacy, Molecular Biology, Toxicology +14

Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?

Russell C. Cattley, John G. DeLuca, Cliff Elcombe et al. · Regulatory Toxicology and Pharmacology · 1998 · 245 citations

Pharmacy, Pathobiology, Toxicology +14

The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1.

Jun Kanno, Lesley Onyon, J HASEMAN et al. · Environmental Health Perspectives · 2001 · 187 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Classification schemes for carcinogenicity based on hazard-identification have become outmoded and serve neither science nor society

Alan R. Boobis, Samuel M. Cohen, Vicki L. Dellarco et al. · Regulatory Toxicology and Pharmacology · 2016 · 83 citations · Full text

Pharmacy, Risk Management, Toxicology +17

The Endocrine Disruptor Screening Program Developed by the U.S. Environmental Protection Agency

Penelope A. Fenner-Crisp, Anthony F. Maciorowski, Gary Timm · Ecotoxicology · 2000 · 66 citations

Pharmacy, Environmental Sciences, Toxicology +14